Hatice Keleş

Hatice Keleş

Auto-generated profile, based on publicly available information

Hatice Keleş

Department Of Cardiovascular Surgery Faculty Of Medicine Kirikkale University Kirikkale Türkiye

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2022 in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
HKHatice Keleş
Hatice Keleş
Yapay Zeka (YZ), bir makine yardımıyla muhakeme, öğrenme, sınıflandırma ve yaratıcılık gibi insani beceriler sergileyen bir dizi algoritmalar bütünüdür. Bu YZ algoritmaları, derin öğrenme ve makine öğrenimi yoluyla insan zekasını taklit etmeye çalışır. Sağlık sektöründeki verilerin artışı ve ulaşılabilirliği, son zamanlardaki başarılı YZ uygulamalarını mümkün kılmıştır. YZ teknolojisi, karmaşık ve büyük verilerin altında saklanan klinik bilgileri su üstüne çıkararak, doktorların yargı ve karar mekanizmalarında büyük fayda sağlayabilir. Geniş klinik kullanımı henüz sınırlı olsa da araştırmalar, YZ'nın hastalıkların teşhisi, tedavisi, izlenmesi, sınıflandırılması ve risk taşıyan durumların ayırt edilmesinde başarıyla kullanılabileceğini göstermektedir. YZ'nın gelecekte doktorların yerini alabileceği düşünülmese de insan yargısının yerini alacağı öngörülmektedir. Bu derlemede, yapay zeka teknolojisinin genel hatları, sağlık hizmetlerinde uygulama alanları, geleceği ve muhtemel etik sorunlar gözden geçirilmektedir.

11 May 2021 in The Heart Surgery Forum
Verified
Journal Article
Closed access
PDF file
YGYildirim Gultekin
Yildirim Gultekin
ABAli Bolat
Ali Bolat
KHKeles Hatice
Keles Hatice
AKAtike Tekeli Kunt
Atike Tekeli Kunt
Background: Aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) frequently is used in the diagnosis and prognosis of liver diseases, however it is also used in the diagnosis and prognosis of many other diseases, such as myocardial infarction, acute ischemic stroke, and peripheral artery disease. Acute kidney injury (AKI) is one of the most important complications after cardiac surgery and is one of the main causes of morbidity and mortality. The purpose of the study was to analyze the relationship between AST to ALT and AKI after isolated coronary artery bypass graft surgery (CABG). Methods: We retrospectively reviewed the prospectively collected data of 253 adult patients, who underwent isolated CABG surgery with normal renal function (baseline serum creatinine value <1.4 mg/dL). Preoperative (T0) and postoperative day 1 and day 3 (T1 and T2) serum AST and ALT levels were analyzed, and AST/ALT was calculated. A preoperative AST/ALT of 1.22 was found to be the best cutoff point for predicting postoperative AKI. Kidney injury was interpreted, according to RIFLE classification. The effect of AST to ALT ratio on AKI after CABG was determined using logistic regression analysis, and the results were expressed as odds ratio (OR) with a 95% confidence interval (CI). A P value < .05 was considered statistically significant. Results: Postoperative AKI occurred in 40 patients (15.8%). On logistic regression analysis, higher AST/ALT both preoperatively and postoperatively were associated with an increased incidence of postoperative AKI (T0: OR, 3.983; 95% CI, 1.940-8.180, P < .001, T1: OR, 2.760; 95% CI, 1.381-5.515, P = .004, T2: OR, 2.515; 95% CI, 1.195-5.294, P = .015). Conclusion: Preoperative and postoperative elevated AST to ALT ratio seems to be associated with an increased incidence of AKI after elective isolated CABG surgery.

1 April 2005 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
HBHakan Boyunağa
Hakan Boyunağa
MBMerih Bayram
Merih Bayram
HKHatice Keleş
Hatice Keleş
AYAykan Yücel
Aykan Yücel
NSNevin Sağsöz
Nevin Sağsöz
EAEmin Özgür Akgül
Emin Özgür Akgül
Background/Aims: Neopterin is a biochemical marker of activated cell-mediated immune response which increases in pathological conditions associated with cellular immune activation as well as in pregnancy where cellular immune response is predominant. The aim of this study was to determine the urinary neopterin level in each trimester of pregnancy and to determine if it can be used as a marker. Methods: 104 healthy pregnant women (mean age 22.10 ± 4.39 years; 36 in the first, 30 in the second and 38 in the third trimester) and 16 non-pregnant healthy women (mean age 20.94 ± 4.48 year) were included. Results: The mean urinary neopterin concentration of all pregnant women was higher than that of non-pregnant women (166.4 ± 31.7 and 103.1 ± 27.5 µmol/mol creatinine respectively, p < 0.01). The mean urinary neopterin levels in each trimester and non-pregnant women were 139.8 ± 49.6, 131 ± 40.2, 227.9 ± 86.5 and 103.1 ± 27.5 µmol/mol creatinine, respectively. Urinary neopterin levels were not significantly different between non-pregnant, first and second trimester groups, but were significantly higher in the third trimester than each of these groups (p < 0.05, p < 0.01 and p < 0.01 respectively). Conclusion: Urinary neopterin levels increase significantly in the third trimester probably due to more predominated cellular immunity. The pathologies causing cellular immune activation, especially in the first two trimesters can be predicted with urinary neopterin levels.

20 April 2007 in Ultraschall in der Medizin - European Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
ASAxel Stang
Axel Stang
HKH. Keles
H. Keles
CSC. von Seydewitz
C. von Seydewitz
SHS. Hentschke
S. Hentschke
EME. Malzfeldt
E. Malzfeldt
DBD. Braumann
D. Braumann
Ziel: Die Ultraschall (US)-gesteuerte Radiofrequenzabalation (RFA) wird zunehmend zur Behandlung von Lebertumoren eingesetzt. Ziel der vorliegenden Studie war, den Einfluss einer interdisziplinären Indikationsstellung auf die klinischen Ergebnisse zu untersuchen. Material und Methoden: Von Januar 2002 bis Dezember 2004 wurden 69 konsekutive Patienten zur RFA-Behandlung vorgestellt. Nach interdisziplinärer Tumorboard-Entscheidung wurden 33 Patienten (47,8 %) mit 70 Lebertumoren mittels 14-gauge Nadelelektroden über einen perkutanen (33) oder intraoperativen Zugangsweg (7) allein oder kombiniert mit einer Resektion (3) oder Chemoembolisation (3) behandelt. 36 Patienten (52,2 %) wurden von der RFA-Behandlung ausgeschlossen, überwiegend wegen zu großer Tumorlast oder Nichtansprechen auf vorrausgegangene Chemotherapie. Alle 69 Patienten wurden im Mittel 20 Monate (6 - 42 Monate) nachbeobachtet, um den klinischen Verlauf zu erfassen, die 33 behandelten Patienten zusätzlich mittels Kontrastmittel-CT zur Beurteilung des lokalen Behandlungserfolgs. Ergebnisse: Eine komplette Tumornekrose wurde bei 64/70 abladierten Läsionen (91,4 %) erreicht. Das Verhältnis von Herdgröße zu Nekrose betrug im Mittel 2,3 cm (0,9 - 5,0) vs. 3,7 cm (2,1 - 5,7). Bei 2 Patienten (6,6 %) traten Komplikationen auf, darunter ein Postablationsyndrom und ein Leberabzess. Zum Zeitpunkt der Tumorboard-Entscheidung unterschieden sich die RFA- (33) und Nicht-RFA-Gruppe (36) insbesondere im mittleren Tumordurchmesser (2,3 vs. 3,5 cm), der Zahl der Läsionen pro Patient (2,1 vs. 3,8), und der Resistenz gegen Chemotherapie (2/33 vs. 22/36). 24/36 der von uns für ungeeignet beurteilten Patienten (66,6 %) wurden auswärts mittels RFA behandelt. Die Überlebenszeiten von in unserer Institution (33) vs. auswärts behandelten (24) vs. nicht behandelten Patienten (12) waren unterschiedlich; 1/33 (3 %) vs. 9/24 (37,5 %) vs. 8/12 (66,6 %) verstarben innerhalb von 6 Monaten und 27/33 (81,2 %) vs. 5/24 (29,2 %) vs. 2/12 (16,7 %) überlebten bei mittlerer Nachbeobachtungzeit von 20 Monaten. Schlussfolgerung: Die US-gesteuerte RFA ist eine sichere lokaltherapeutische Option zur Destruktion kleiner Lebertumore (< 3 cm). Sorgfältig interdisziplinär ausgewählte Patienten können profitieren, der unkritische Einsatz führt zu unbefriedigenden klinischen Behandlungsergebnissen. Purpose: Ultrasonography (US)-guided Radiofrequency ablation (RFA) is increasingly used to treat liver tumours. The aim of this study was to evaluate the impact of multidisciplinary patient selection on clinical results. Materials and Methods: From January 2002 to December 2004, 69 consecutive patients with malignant hepatic tumours were presented to our clinic for RFA-treatment. After a multidisciplinary tumour board decision, 33 patients (47.8 %) with 70 liver tumours underwent RFA using a 14-gauge needle electrode via a percutaneous (26) or surgical (7) approach, either alone or combined with resection (3) or chemoembolisation (3). 36 patients (52.2 %) were excluded from RFA treatment, mainly because of extensive disease or failure of prior chemotherapy. With a median of 20 months (range 6 - 42 months), all 69 patients were followed clinically to assess survival, and the 33 patients who received additional treatment were examined by contrast-enhanced CT to assess local success. Results: Complete necrosis was obtained in 64/70 of ablated tumours (91.4 %).The corresponding mean sizes (ranges) of lesion vs. necrosis achieved were 2.3 cm (0.9 - 5.0) vs. 3.7 cm (2.1 - 5.7). Two complications (6.6 %) occurred, including one liver abscess and one postablational syndrome. At the time of the tumour board decision, the RFA (33) and non-RFA (36) group differed in mean sizes of tumours (2.3 vs. 3.5 cm), average tumours per patient (2.1 vs. 3.8), and failure of prior chemotherapy (2/33 vs. 22/36). From 36 patients judged to be ineligible for RFA, 24 (66.6 %) underwent RFA at another institution. When comparing survival of patients who underwent RFA at our institution (33) vs. those who underwent RFA outside (24) vs. those who underwent no RFA (12), 1/33 (3 %) vs. 9/24 (37.5 %) vs. 8/12 (66.6 %) died within 6 month and 27/33 (81.2 %) vs. 5/24 (29.2 %) vs. 2/12 (16.7 %) were alive after 20 months median follow up. Conclusion: US-guided RFA offers a safe local treatment option to destroy small liver tumours (< 3 cm). Carefully and multidisciplinary selected patients may derive benefit, but uncritical application leads to unsatisfying clinical results.

1 May 2023 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
MOMehmet Ruhi Onur
Mehmet Ruhi Onur
YOYakup Ozbay
Yakup Ozbay
IIİlkay İdilman
İlkay İdilman
AKAli Devrim Karaosmanoğlu
Ali Devrim Karaosmanoğlu
SRSelma Uysal Ramadan
Selma Uysal Ramadan
MKMuşturay Karçaaltıncaba
Muşturay Karçaaltıncaba
To evaluate the frequency of abdominal computed tomography (CT) findings in patients with coronavirus disease-2019 (COVID-19) and interrogate the relationship between abdominal CT findings and patient demographic features, clinical findings, and laboratory test results as well as the CT atherosclerosis score in the abdominal aorta. This study was designed as a multicenter retrospective study. The abdominal CT findings of 1.181 patients with positive abdominal symptoms from 26 tertiary medical centers with a positive polymerase chain-reaction test for severe acute respiratory syndrome coronavirus 2 were reviewed. The frequency of ischemic and non-ischemic CT findings as well as the association between CT findings, clinical features, and abdominal aortic calcific atherosclerosis score (AA-CAS) were recorded. Ischemic and non-ischemic abdominal CT findings were detected in 240 (20.3%) and 328 (27.7%) patients, respectively. In 147 patients (12.4%), intra-abdominal malignancy was present. The most frequent ischemic abdominal CT findings were bowel wall thickening (n = 120; 10.2%) and perivascular infiltration (n = 40; 3.4%). As for non-ischemic findings, colitis (n = 91; 7.7%) and small bowel inflammation (n = 73; 6.2%) constituted the most frequent disease processes. The duration of hospital stay was found to be higher in patients with abdominal CT findings than in patients without any positive findings (13.8 ± 13 vs. 10.4 ± 12.8 days, P < 0.001). The frequency of abdominal CT findings was significantly higher in patients who did not survive the infection than in patients who were discharged after recovery (41.7% vs. 27.4%, P < 0.001). Increased AA-CAS was found to be associated with a higher risk of ischemic conditions in abdominal CT examinations. Abdominal symptoms in patients with COVID-19 are usually associated with positive CT findings. The presence of ischemic findings on CT correlates with poor COVID-19 outcomes. A high AA-CAS is associated with abdominal ischemic findings in patients with COVID-19.

29 July 2024 in Eskisehir Medical Journal, Eskisehir City Hospital
Verified
Journal Article
Open access
PDF file
YGYıldırım Gültekin
Yıldırım Gültekin
ABAli Bolat
Ali Bolat
MÖMerih Özbayburtlu
Merih Özbayburtlu
HKHatice Keleş
Hatice Keleş
AKAtike Tekeli Kunt
Atike Tekeli Kunt
HAHatice Aktaş
Hatice Aktaş
ÖZET Giriş: Düşük molekül ağırlıklı heparinler, venöz tromboembolizmin profilaksisinde ruhsatlıdır ancak arteriyel trombozun profilaksisinde yoktur. Bu çalışmada sıçan modelinde postoperatif düşük molekül ağırlıklı heparin tinzaparinin uygulanmasının arteriyel tromboz oranına etkisinin değerlendirilmesi amaçlandı. Yöntemler: On altı erkek Wistar Albino sıçanın sağ femoral arterleri transvers olarak kesildi ve daha sonra sürekli dikişle onarıldı. Sekiz sıçana ameliyat sonrası üç gün boyunca 175 IU/kg/gün tinzaparin verilirken, geri kalan sekiz sıçana tinzaparin verilmedi. Tüm sıçanlar ameliyat sonrası dördüncü günde tekrar ameliyata alınana kadar damar dolaşımı, kanama ve hematom açısından günlük olarak kontrol edildi. Vasküler açıklığı araştırmak ve histopatolojik inceleme için onarılan femoral arterden bir vasküler doku örneğini çıkarmak için yeniden ameliyat yapıldı. Tinzaparinin etkinliğini göstermek amacıyla anti-faktör Xa aktivitesinin saptanması için de bir kan örneği alındı. Bulgular: Postoperatif üç günlük takipte tinzaparin uygulanan sıçanların hiçbirinde damar dolaşım bozukluğu saptanmazken, tinzaparin tedavisi uygulanmayan iki sıçanda (%25) damar dolaşım bozukluğu tespit edildi. Her iki gruptaki sıçanların hiçbirinde cerrahi bölgede kanama veya hematom gelişmedi. Postoperatif dönemde tinzaparin uygulanan sıçanlarda anti-faktör Xa aktivitesinin, tinzaparin uygulanmayan sıçanlara göre anlamlı derecede yüksek olduğu görüldü (p<0,001). Histopatolojik incelemede tinzaparin tedavisi gören yalnızca bir sıçanda (%12,5) ve tinzaparin tedavisi uygulanmayan yedi sıçanda (%87,5) femoral arter insizyon hattında trombüs ve fibrin oluşumu saptandı (p˂0,001). Hiçbir grupta intimal hiperplazi saptanmadı ancak her iki grupta da karışık tipte inflamatuar hücre infiltrasyonu ve sütür çevresinde endotelyal ve fibroblastik aktivite dikkat çekti. Sonuç: Sıçan modelinde postoperatif subkutan 175 IU/kg/gün tinzaparin uygulamasının arteriyel cerrahi girişimlerde arteriyel tromboz oranını etkili bir şekilde azalttığı görüldü. Anahtar Kelimeler: Arteriyel tromboz, düşük molekül ağırlıklı heparin, tinzaparin